Pharmacist Patient Safety | Specialty Pharmacy | Treatment Guidelines Written 2 credit hours

Bipolar Disorder and Schizophrenia are complex conditions that can significantly affect patient outcomes, quality of life, and long-term health if not managed appropriately. This course discusses clinical presentation and evidence-based pharmacologic management of Bipolar Disorder and Schizophrenia, with emphasis on therapeutic goals, medication selection, safety considerations, and monitoring strategies. You will gain practical tools to optimize medication use, support adherence, and provide patient-centered counseling to improve outcomes in individuals living with Bipolar Disorder and Schizophrenia.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Describe the clinical manifestations and overall disease burden associated with Bipolar Disorder and Schizophrenia.
2. Summarize evidence-based pharmacologic treatment options for Bipolar Disorder and Schizophrenia, including place in therapy and therapeutic goals.
3. Design a patient-specific medication management plan for a patient with Bipolar Disorder and Schizophrenia that ensures appropriate therapy selection, safe administration, adherence support, monitoring, and patient counseling.

Faculty

Jill Paslier, PharmD, CSP, FISMP

Disclosures:

Jill Paslier has no relevant financial relationships with ineligible companies to disclose. 

Course Details